Introduction of comprehensive public sector insurance coverage is threatening to limit operations of private insurers among the expatriate population. The ministry s ban on private pharmacies offering discounts on pharmaceutical products will undercut their margins. A regional drug price harmonisation, as proposed by the Gulf Cooperation Council, will affect margins. An expansion of government cost-containment measures - most notably the implementation of extensive price cuts - is threatening to slow market development. Any fall in oil prices could result in a reduction in government industry investment, which could slow pharmaceutical market growth. ...An expansion of government cost-containment measures - most notably the implementation of extensive price cuts - is threatening to slow market development. Any fall in oil prices could result in a reduction in government industry investment, which could slow pharmaceutical market growth.
...BMI View: The UAE will remain one of the most attractive pharmaceutical and healthcare markets in the Middle East and Africa Region. A rising chronic disease burden will drive demand for high-value medicines, particularly cancer drugs. ...A rising chronic disease burden will drive demand for high-value medicines, particularly cancer drugs. The market is dominated by patented medicines, mainly imported from Western suppliers due to their perceived superiority. However, this current model is unsustainable over the long term and as such, the supply of generic cancer medicines in the UAE will increasingly be satisfied by the domestic industry, limiting the country s escalating healthcare costs. ...The market is dominated by patented medicines, mainly imported from Western suppliers due to their perceived superiority. However, this current model is unsustainable over the long term and as such, the supply of generic cancer medicines in the UAE will increasingly be satisfied by the domestic industry, limiting the country s escalating healthcare costs.
...In August ----, the Ministry of Health (MoH) reduced the prices of --- drugs from between ---- , including medicines for cardiovascular diseases, central nervous system disorders, infections, respiratory diseases, endocrine and others. In August ----, UAE-based Julphar reported a -.- y-o-y decline in sales revenue - amounting to AED---.-mn (USD---.-mn) - and a --.- y-o-y fall in net profits - recorded at AED---.-bn (USD---.-mn) for H---. ...